Skip to content

A clinical study examining whether magnesium sulfate can help reduce agitation and confusion in children as they wake up from anesthesia after lower-abdominal surgery.

Effect of magnesium sulphate on emergence delirium in pediatric patient undergoing infraumbilical surgery: a double blinded randomized controlled trial - Nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/099180
Enrollment
72
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Magnesium Sulphate Group: Just before giving general anesthesia, intervention patients will be given magnesium sulphate bolus at 30 mg/kg over 15 minutes i.e. 2mg/kg/min just before i

Sponsors

All India Institute of Medical Sciences Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Paediatric patient age 2-8 years 2. Patient scheduled for elective infraumbilical surgeries 3. ASA I and II

Exclusion criteria

Exclusion criteria: 1.History of hypersensitivity 2. Neurological disorders, developmental delay, or psychiatric illness 3. pre-existing electrolyte imbalance 4. cardiac conduction abnormalities 5. Currently of anti-epileptic drugs 6. Neuromuscular disease pulmonary, hepatobiliary or renal disease..

Design outcomes

Primary

MeasureTime frame
To assess the effects of Magnesium Sulphate on the incidence of emergence delirium in pediatric patients undergoing elective infraumbilical surgery using PAED scoreTimepoint: Just before induction till postoperative period of 60 minutes

Secondary

MeasureTime frame
1.To assess severity of emergence delirium using PAED score. 2. To assess and evaluate post operative pain score using FLACC score. 3. To evaluate need of rescue sedatives. 4. To assess the time of emergence. 5. To see and evaluate any adverse events.Timepoint: Just before induction till postoperative period of 60 minutes

Countries

India

Contacts

Public ContactDr Kunal Singh

All India Institute of Medical Sciences Patna

drsinghkunal@gmail.com9411514945

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026